Korner B, Jensen H K
Br J Vener Dis. 1976 Dec;52(6):404-8. doi: 10.1136/sti.52.6.404.
Prompted by the sensitivity of trichomonads to metronidazole and nifuratel in clinical practice, a study was conducted in 1971-1972 of 63 consecutive strains of Trichomonas vaginalis isolated from women with clinically refractory vaginal discharge. Their susceptibility to metronidazole, tinidazole, and nifuratel was tested, using a serial tube dilution technique. The minimum concentrations which in 48 hrs caused immobilization and lysis of trichomonads cultured in Diamond's medium was assessed. No differences in drug potency could be determined. The median trichomonistatic and trichomonicidal concentrations were 0-1 and 0-6 mug/ml. respectively when using an inoculum of 10,000 organisms per ml. An inoculum of 100,000 per ml. resulted in inhibitory concentrations of 1-0 and killing concentrations of 3-3 mug./ml. These levels are readily attained in blood and vaginal tissue after oral ingestion of the two imidazole derivatives. Thus, metronidazole has maintained its efficacy since it was first introduced more than a decade ago. The few therapeutic failures with metronidazole and tinidazole are considered to have been caused by pharmacokinetic deficiencies in the patients, or by re-infection.
鉴于临床实践中滴虫对甲硝唑和硝呋太尔敏感,1971 - 1972年对63株连续从患有临床难治性白带的女性中分离出的阴道毛滴虫菌株进行了一项研究。采用连续试管稀释技术检测了它们对甲硝唑、替硝唑和硝呋太尔的敏感性。评估了在48小时内导致在戴蒙德培养基中培养的滴虫固定和裂解的最低浓度。无法确定药物效力的差异。当每毫升接种10000个生物体时,滴虫生长抑制和杀滴虫的中位数浓度分别为0 - 1微克/毫升和0 - 6微克/毫升。每毫升接种100000个生物体时,抑制浓度为1 - 0微克/毫升,杀灭浓度为3 - 3微克/毫升。口服这两种咪唑衍生物后,血液和阴道组织中很容易达到这些水平。因此,自十多年前首次引入以来,甲硝唑一直保持其疗效。少数甲硝唑和替硝唑治疗失败被认为是由患者的药代动力学缺陷或再次感染引起的。